Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease

BACKGROUND: Current guidelines recommend dual anti-platelet therapy, aspirin and clopidogrel, for patients treated with drug-eluting stent for coronary heart disease. In a few small trials, addition of cilostazol on dual anti-platelet therapy (triple anti-platelet therapy) showed better late luminal...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung-Pyo, Suh, Jung-Won, Park, Kyung Woo, Lee, Hae-Young, Kang, Hyun-Jae, Koo, Bon-Kwon, Chae, In-Ho, Choi, Dong-Ju, Rha, Seung-Woon, Bae, Jang-Whan, Cho, Myeong-Chan, Kwon, Taek-Geun, Bae, Jang-Ho, Kim, Hyo-Soo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936395/
https://www.ncbi.nlm.nih.gov/pubmed/20735821
http://dx.doi.org/10.1186/1745-6215-11-87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936395/
https://www.ncbi.nlm.nih.gov/pubmed/20735821
http://dx.doi.org/10.1186/1745-6215-11-87

Ejemplares similares